ACS Combinatorial Science
Research Article
(7) (a) Pradeep, C. R.; Kuttan, G. Effect of piperine on the inhibition
of lung metastasis induced B16F-10 melanoma cells in mice. Clin. Exp.
Metastasis 2002, 19, 703−708. (b) Chen, J.-J.; Huang, Y.-C.; Chen, Y.-
C.; Huang, Y.-T.; Wang, S.-W.; Peng, C.-Y.; Teng, C.-M.; Chen, I.-S.
Cytotoxic amides from Piper sintenense. Planta Med. 2002, 68, 980−
985. (c) Sunila, E. S.; Kuttan, G. Immunomodulatory and antitumor
activity of Piper longum Linn. and piperine. J. Ethnopharmacol. 2004,
90, 339−346. (d) Selvendiran, K.; Singh, J. P. V.; Sakthisekaran, D. In
vivo effect of piperine on serum and tissue glycoprotein levels in
benzo(a)pyrene induced lung carcinogenesis in Swiss albino mice.
Pulm. Pharmacol. Ther. 2006, 19, 107−111. (e) Bezerra, D. P.; Pessoa,
C.; de Moraes, M. O.; de Alencar, N. M. N.; Mesquita, R. O.; Lima, M.
W.; Alves, A. P. N. N.; Pessoa, O. D. L.; Chaves, J. H.; Silveira, E. R.;
Costa-Lotufo, L. V. In vivo growth inhibition of sarcoma 180 by
piperlonguminine, an alkaloid amide from the Piper species. J. Appl.
Toxicol. 2008, 28, 599−607.
(8) (a) Szallasi, A.; Cortright, D. N.; Blum, C. A.; Eid, S. R. The
vanilloid receptor TRPV1: 10 years from channel cloning to antagonist
proof-of-concept. Nat. Rev. Drug Discovery 2007, 6, 357−372.
(b) Gavva, N. R.; Tamir, R.; Qu, Y.; Klionsky, L.; Zhang, T. J.;
Immke, D.; Wang, J.; Zhu, D.; Vanderah, T. W.; Porreca, F.; Doherty,
E. M.; Norman, M. H.; Wild, K. D.; Bannon, A. W.; Louis, J.-C.;
Treanor, J. J. S. AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-
dihydrobenzo[b][1,4]dioxin-6-yl)acrylamide], a novel vanilloid recep-
tor 1 (TRPV1) antagonist with antihyperalgesic properties. J.
(15) (a) Maryanoff, B. E.; Reitz, A. B. The wittig olefination reaction
and modifications involving phosphoryl-stabilized carbanions. Stereo-
chemistry, mechanism, and selected synthetic aspects. Chem. Rev.
1989, 89, 863−927. (b) Nagaoka, H.; Kishi, Y. Further synthetic
studies on rifamycin S. Tetrahedron 1981, 37, 3873−3888.
(16) The reaction of 1a with electron-deficient aryl amines, such as
methyl 4-aminobenzoate, resulted in the incomplete conversion in a
given reaction time and temperature. A longer reaction time, higher
temperature (40 °C), and excess succinimidyl ester 1a (3 equiv) were
required to drive this reaction to completion; 5 days with base
additives or 7 days without base additives.
(17) In the case of the reaction performed in the presence of base
additives, acidic workup was additionally required to remove basic
additives.
(18) Siu, J.; Baxendale, I. R.; Lewthwaite, R. A.; Ley, S. V. A phase-
switch purification approach for the expedient removal of tagged
reagents and scavengers following their application in organic
synthesis. Org. Biomol. Chem. 2005, 3, 3140−3160.
(19) Jackson, J. A.; Hammond, G. B.; Wiemer, D. F. Synthesis of α-
phosphono lactones and esters through a vinyl phosphate-
phosphonate rearrangement. J. Org. Chem. 1989, 54, 4750−4754.
(20) Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.
Experimental and computational approaches to estimate solubility and
permeability in drug discovery and development settings. Adv. Drug
Delivery Rev. 1997, 23, 3−25.
(21) Veber, D. F.; Johnson, S. R.; Cheng, H.-Y.; Smith, B. R.; Ward,
K. W.; Kopple, K. D. Molecular properties that influence the oral
bioavailability of drug candidates. J. Med. Chem. 2002, 45, 2615−2623.
(22) The library members were filtered using Filter by Lipinski and
Veber Rules protocol in the Discovery Studio, version 3.5; Accelrys, Inc.:
San Diego, CA, 2012.
(23) Ohki-Hamazaki, H.; Watase, K.; Yamamoto, K.; Ogura, H.;
Yamano, M.; Yamada, K.; Maeno, H.; Imaki, J.; Kikuyama, S.; Wada,
E.; Wada, K. Mice lacking bombesin receptor subtype-3 develop
metabolic defects and obesity. Nature 1997, 390, 165−169.
(24) (a) Hadden, M.; Goodman, A.; Guo, C.; Guzzo, P. R.;
Henderson, A. J.; Pattamana, K.; Ruenz, M.; Sargent, B. J.; Swenson,
B.; Yet, L.; Liu, J.; He, S.; Sebhat, I. K.; Lin, L. S.; Tamvakopoulos, C.;
Peng, Q.; Kan, Y.; Palyha, O.; Kelly, T. M.; Guan, X.-M.; Metzger, J.
M.; Reitman, M. L.; Nargund, R. P. Synthesis and SAR of heterocyclic
carboxylic acid isosteres based on 2-biarylethylimidazole as bombesin
receptor subtype-3 (BRS-3) agonists for the treatment of obesity.
Bioorg. Med. Chem. Lett. 2010, 20, 2912−2915. (b) Guan, X.-M.; Chen,
H.; Dobbelaar, P. H.; Dong, Y.; Fong, T. M.; Gagen, K.; Gorski, J.; He,
S.; Howard, A. D.; Jian, T.; Jiang, M.; Kan, Y.; Kelly, T. M.; Kosinski,
J.; Lin, L. S.; Liu, J.; Marsh, D. J.; Metzger, J. M.; Miller, R.; Nargund,
R. P.; Palyha, O.; Shearman, L.; Shen, Z.; Stearns, R.; Strack, A. M.;
Stribling, S.; Tang, Y. S.; Wang, S.-P.; White, A.; Yu, H.; Reitman, M.
L. Regulation of energy homeostasis by bombesin receptor subtype-3:
selective receptor agonists for the treatment of obesity. Cell Metab.
2010, 11, 101−112. (c) Feng, Y.; Guan, X.-M.; Li, J.; Metzger, J. M.;
Zhu, Y.; Juhl, K.; Zhang, B. B.; Thornberry, N. A.; Reitman, M. L.;
Zhou, Y.-P. Bombesin receptor subtype-3 (BRS-3) regulates glucose-
stimulated insulin secretion in pancreatic islets across multiple species.
Endocrinology 2011, 152, 4106−4115.
Pharmacol. Exp. Ther. 2005, 313, 474−484. (c) Varga, A.; Nem
́
eth,
, E.;
́
J.; Szabo,
́
A.; McDougall, J. J.; Zhang, C.; Elekes, K.; Pinter
́
Szolcsan
́
yi, J.; Helyes, Z. Effects of the novel TRPV1 receptor
antagonist SB366791 in vitro and in vivo in the rat. Neurosci. Lett.
2005, 385, 137−142. (d) Niiyama, Y.; Kawamata, T.; Yamamoto, J.;
Furuse, S.; Namiki, A. SB366791, A TRPV1 antagonist, potentiates
analgesic effects of systemic morphine in a murine model of bone
cancer pain. Br. J. Anaesthesia 2009, 102, 251−258.
(9) (a) Ward, M. R.; Sasahara, T.; Agrotis, A.; Dilley, R. J.; Jennings,
G. L.; Bobik, A. Inhibitory effects of tranilast on expression of
transforming growth factor-β isoforms and receptors in injured
arteries. Atherosclerosis 1998, 137, 267−275. (b) Zammit, S. C.; Cox,
A. J.; Gow, R. M.; Zhang, Y.; Gilbert, R. E.; Krum, H.; Kelly, D. J.;
Williams, S. J. Evaluation and optimization of antifibrotic activity of
cinnamoyl anthranilates. Bioorg. Med. Chem. Lett. 2009, 19, 7003−
7006.
(10) (a) Li, Y.; Zhang, Y.; Huang, Z.; Cao, X.; Gao, K. Stereoselective
synthesis of naturally occurring unsaturated amide alkaloids by a
modified Ramberg−Backlund reaction. Can. J. Chem. 2004, 82, 622−
̈
́
630 and references reported therein. (b) Concellon, J. M.; Rodríguez-
Solla, H.; Díaz, P. Sequential reactions promoted by manganese:
Completely stereoselective synthesis of (E)-α,β-unsaturated amides,
ketones, aldehydes, and carboxylic acids. J. Org. Chem. 2007, 72,
7974−7979. (c) Chen, C.-C.; Ho, J.-C.; Chang, N.-C. A practical and
efficient synthesis of (E)-β-aryl-α,β-unsaturated amides. Tetrahedron
2008, 64, 10350−10354. (d) Leung, P. S.-W.; Teng, Y.; Toy, P. H.
Chromatography-free Wittig reactions using a bifunctional polymeric
reagent. Org. Lett. 2010, 12, 4996−4999.
(11) Schobert, R.; Siegfried, S.; Gordon, G. J. Three-component
synthesis of (E)-α,β-unsaturated amides of the piperine family. J.
Chem. Soc., Perkin Trans. 1 2001, 2393−2397.
(25) Liu, P.; Lanza, T. J.; Chioda, M.; Jones, C.; Chobanian, H. R.;
Guo, Y.; Chang, L.; Kelly, T. M.; Kan, Y.; Palyha, O.; Guan, X.-M.;
Marsh, D. J.; Metzger, J. M.; Ramsay, K.; Wang, S.-P.; Strack, A. M.;
Miller, R.; Pang, J.; Lyons, K.; Dragovic, J.; Ning, J. G.; Schafer, W. A.;
Welch, C. J.; Gong, X.; Gao, Y.-D.; Hornak, V.; Ball, R. G.; Tsou, N.;
Reitman, M. L.; Wyvratt, M. J.; Nargund, R. P.; Lin, L. S. Discovery of
benzodiazepine sulfonamide-based bombesin receptor subtype 3
agonists and their unusual chirality. ACS Med. Chem. Lett. 2011, 2,
933−937 and references reported therein.
(26) (a) Sebhat, I. K.; Franklin, C.; Lo, M. M.-C.; Chen, D.; Jewell, J.
P.; Miller, R.; Pang, J.; Palyha, O.; Kan, Y.; Kelly, T. M.; Guan, X.-M.;
Marsh, D. J.; Kosinski, J. A.; Metzger, J. M.; Lyons, K.; Dragovic, J.;
Guzzo, P. R.; Reitman, M. L.; Nargund, R. P.; Wyvratt, M. J.; Lin, L. S.
Discovery of MK-5046, a potent, selective bombesin receptor subtype-
́
̂
(12) Weber, C.; Bielik, A.; Szendrei, G. I.; Keseru, G. M.; Greiner, I.
Solid-phase synthesis of an N-(phenylalkyl)cinnamide library via
Horner−Wadsworth−Emmons reaction. Bioorg. Med. Chem. Lett.
2004, 14, 1279−1281.
(13) We have previously reported the use of Girard’s reagent T as a
carbonyl compound scavenger in solution-phase library generation.
See ref 14.
(14) (a) Kim, S.; Ko, H.; Kim, S.; Lee, T. Solution-phase synthesis of
a library of biaryl amides using girard’s reagent T as an acid chloride
scavenger. J. Comb. Chem. 2002, 4, 549−551. (b) Hwang, S.; Choi, S.
Y.; Lee, J. H.; Kim, S.; In, J.; Ha, S. K.; Lee, E.; Kim, T.-Y.; Kim, S. Y.;
Choi, S.; Kim, S. Identification of a potent and noncytotoxic inhibitor
of melanin production. Bioorg. Med. Chem. 2010, 18, 5602−5609.
G
dx.doi.org/10.1021/co400003d | ACS Comb. Sci. XXXX, XXX, XXX−XXX